Genprex (GNPX) Depreciation & Amortization - Total (2016 - 2024)
Genprex (GNPX) posted Depreciation & Amortization - Total of $463.0 for Q4 2024, down 63.6% on a QoQ basis from $1272.0 in Q3 2024, and down 86.49% year-over-year from $3426.0 in Q1 2024.
Powered by 
Analysis
Genprex (GNPX) Depreciation & Amortization - Total (2016 - 2024) Analysis & Trends
Genprex has reported Depreciation & Amortization - Total for 9 years, with the latest figure at $463.0 in Q4 2024.
- On a quarterly basis, Depreciation & Amortization - Total fell 86.49% year-over-year to $463.0 in Q4 2024; TTM through Dec 2024 was $6693.0, a 55.39% decrease from a year earlier, with the FY2024 full-year figure at $6693.0, down 55.39% from the prior year.
- Depreciation & Amortization - Total was $463.0 for Q4 2024 at Genprex, down from $1272.0 in the prior quarter.
- The five-year high for Depreciation & Amortization - Total was $6955.0 in Q4 2021, with the low at $463.0 in Q4 2024.
- Average Depreciation & Amortization - Total over 5 years is $4653.6, with a median of $5533.5 recorded in 2020.
- The sharpest annual moves came in 2022 and 2024: Depreciation & Amortization - Total jumped 129.78% in 2022, then sank 86.49% in 2024.
- Over 5 years, Depreciation & Amortization - Total stood at $5934.0 in 2020, then gained by 17.21% to $6955.0 in 2021, then fell by 12.61% to $6078.0 in 2022, then plunged by 43.63% to $3426.0 in 2023, then tumbled by 86.49% to $463.0 in 2024.
- The last three Depreciation & Amortization - Total figures came in at $463.0 (Q4 2024), $1272.0 (Q3 2024), and $2288.0 (Q2 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | - |
| 10 | Genprex | 1.61 Mn | -13.55 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 463.00 |
| Sep 30, 2024 | 1,272.00 |
| Jun 30, 2024 | 2,288.00 |
| Mar 31, 2024 | 2,670.00 |
| Dec 31, 2023 | 3,426.00 |
| Sep 30, 2023 | 3,724.00 |
| Jun 30, 2023 | 3,837.00 |
| Mar 31, 2023 | 4,016.00 |
| Dec 31, 2022 | 6,078.00 |
| Sep 30, 2022 | 6,224.00 |
| Jun 30, 2022 | 6,544.00 |
| Mar 31, 2022 | 6,730.00 |
| Dec 31, 2021 | 6,955.00 |
| Sep 30, 2021 | 6,489.00 |
| Jun 30, 2021 | 2,848.00 |
| Mar 31, 2021 | 6,730.00 |
| Dec 31, 2020 | 5,934.00 |
| Sep 30, 2020 | 5,714.00 |
| Jun 30, 2020 | 5,776.00 |
| Mar 31, 2020 | 5,353.00 |